Policy developments of health technology assessment in the European Union

Authors

  • Aleksandra Baran-Kooiker Department of Pharmacoeconomics, Faculty of Pharmacy, Medical University of Warsaw
  • Marcin Czech Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw
  • Malwina Hołownia-Voloskova 4Department of Clinical and Experimental Farmacology, Faculty of Pharmacy, Medical University of Warsaw

DOI:

https://doi.org/10.18388/pb.2019_285

Abstract

The purpose of the note below is to familiarize readers with the current status and future initiatives of cooperation in the field of health technology assessment (HTA) in the European Union (EU). The European Commission is trying to create a framework for efficient collaboration between member states of EU in the field of HTA and is gradually working on strengthening it. The following initiatives, projects and programs have already been implemented:

-  Project on Coordination and Development of Health Care Technology Assessment in Europe

-  The European Collaboration for Assessment of Health Interventions and Technology

-  European Network for Health Technology Assessment 

-  Beneluxa Initiative, The Valletta Declaration, FINOSE and Fair and Affordable Pricing

-  European Network for Health Technology Assessment

Currently there is an ongoing proposal for an HTA Regulation of the European Parliament and the Council, which is the measurable result of this cooperation. A key element of the proposed regulation is a centralized joint clinical assessment (for HTA purposes) of the efficacy of the medicinal product/medical device.

Downloads

Download data is not yet available.

Downloads

Published

2019-11-29

Issue

Vol. 65 No. 4 (2019)

Section

Articles

License

All journal contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made, ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. There are no additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Copyright for all published papers © stays with the authors.

Copyright for the journal: © Polish Biochemical Society.